Immunodiagnostics Market OverviewThe growing adoption of the point-of-care testing (POCT) will drive growth prospects for global immunodiagnostics market until end of 2027. Few of life-threatening conditions which need thoughtful attention include acute cardiac infarction and sepsis. Such serious situations with high death rate drive necessity for the POCT, which, in turn, increases the demand for the immunodiagnostics testing. One of areas of focus for the non-traditional and traditional healthcare companies are the POCT for cardiovascular biomarkers. Moreover, POCT is accurate, fast, portable, and very simple to interpret, that helps healthcare providers in alternate healthcare settings. Furthermore, the cost of the POCT is very low because of the small capillary tubes which need fewer reagents.
Significant progression in immunodiagnostics have enhanced diagnosis of the complex interactive network. Increase in prevalence and incidences of infectious diseases (such as HIV, hepatitis, STDs, and others), cardiovascular diseases (CVDs), cancers, and various other chronic diseases have advanced immunodiagnostics market. Additionally, rising geriatric population and altering lifestyle and demographics supplementary propel market. Growing awareness and technological advancements about immunodiagnostics drive global market. Though stringent regulatory scenarios confine global immunodiagnostics market.
Immunodiagnostics Market Segment OverviewRise in incidences of various infectious diseases (including HIV, hepatitis B, STI, and others), CVDs, cancer, gastrointestinal, and various other chronic diseases around world owing to growth in elderly population and changes in the demographics and lifestyle are major factors to drive growth of immunodiagnostics market. In addition, technical advancement in assays, diagnosis kits, and analysers and surge in awareness of preventive health measures among medical professionals and patient further stimulate demand for various immunodiagnostics products hence boosting growth. Though, numerous factors are anticipated to restrain market development. Impact of drivers is projected to be higher than restraints. Moreover, increase in effect of drivers and restraints is expected to reveal various new market opportunities for the key players manufacturing the immunodiagnostics products especially assays and kits.
Immunodiagnostics Regional OverviewNorth America was largest immunodiagnostics market in 2020, and region will offer numerous growth opportunities to the market vendors over the forecast period. Aspects such as fast-growing elderly population and high prevalence of various chronic and infectious diseases will meaningfully drive the immunodiagnostics market growth in the region throughout forecast period.
Asia-Pacific region is predictable to grow with highest CAGR during forecast period owed to improvement in favorable regulatory reforms, public and private healthcare facility, presence of large population pool, and growing chronic diseases.
Immunodiagnostics Market Competitor overviewThe market for immunodiagnostics is concentrated. The major players are concentrating on developing advanced technologies to improve performance parameters of the immunodiagnostics. Since global immunodiagnostics market is in growth phase, major vendors are challenging each other to consolidate the position in market and to attract new customers.
Immunodiagnostics Market, Key Players• Abbott Laboratories
• bioMérieux SA
• Danaher Corp.
• F. Hoffmann-La Roche Ltd.
• OraSure Technologies Inc.
• Quest Diagnostics Inc.
• Siemens AG
• Sysmex Corp.
• Tecan Group Ltd.
• Thermo Fisher Scientific Inc.
Immunodiagnostics Market SegmentationImmunodiagnostics Market, By Products
• Reagents and consumables
• Immunodiagnostic systems
Immunodiagnostics Market, By Application
• Oncology and endocrinology
• Hepatitis and retrovirus
• Infectious disease
• GI stool
• Other applications
Immunodiagnostics Market, By End Use
• Hospitals
• Diagnostic laboratories
• PPLs
Immunodiagnostics market, By Region:
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
Immunodiagnostics MARKET STUDY GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2020-2027
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Immunodiagnostics Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Segment 1
- 5.2.1. Sub-Segment 1
- 5.2.2. Sub-Segment 2
- 5.3. Market Analysis, Insights and Forecast – By Segment 2
- 5.3.1. Sub-Segment 1
- 5.3.2. Sub-Segment 2
- 5.3.3. Sub-Segment 3
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast – By Segment 3
- 5.4.1. Sub-Segment 1
- 5.4.2. Sub-Segment 2
- 5.4.3. Sub-Segment 3
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Latin America
- 5.5.3. Europe
- 5.5.4. Asia Pacific
- 5.5.5. Middle East and Africa
6. North America Immunodiagnostics Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Segment 1
- 6.2.1. Sub-Segment 1
- 6.2.2. Sub-Segment 2
- 6.3. Market Analysis, Insights and Forecast – By Segment 2
- 6.3.1. Sub-Segment 1
- 6.3.2. Sub-Segment 2
- 6.3.3. Sub-Segment 3
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast – By Segment 3
- 6.4.1. Sub-Segment 1
- 6.4.2. Sub-Segment 2
- 6.4.3. Sub-Segment 3
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast – By Country
7. Latin America Immunodiagnostics Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Segment 1
- 7.2.1. Sub-Segment 1
- 7.2.2. Sub-Segment 2
- 7.3. Market Analysis, Insights and Forecast – By Segment 2
- 7.3.1. Sub-Segment 1
- 7.3.2. Sub-Segment 2
- 7.3.3. Sub-Segment 3
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast – By Segment 3
- 7.4.1. Sub-Segment 1
- 7.4.2. Sub-Segment 2
- 7.4.3. Sub-Segment 3
- 7.4.4. Others
- 7.5. Insights and Forecast – By Country
- 7.5.1. Brazil
- 7.5.2. Mexico
- 7.5.3. Rest of Latin America
8. Europe Immunodiagnostics Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Segment 1
- 8.2.1. Sub-Segment 1
- 8.2.2. Sub-Segment 2
- 8.3. Market Analysis, Insights and Forecast – By Segment 2
- 8.3.1. Sub-Segment 1
- 8.3.2. Sub-Segment 2
- 8.3.3. Sub-Segment 3
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast – By Segment 3
- 8.4.1. Sub-Segment 1
- 8.4.2. Sub-Segment 2
- 8.4.3. Sub-Segment 3
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. UK
- 8.5.2. Germany
- 8.5.3. France
- 8.5.4. Italy
- 8.5.5. Spain
- 8.5.6. Russia
- 8.5.7. Rest of Europe
9. Asia Pacific Immunodiagnostics Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Segment 1
- 9.2.1. Sub-Segment 1
- 9.2.2. Sub-Segment 2
- 9.3. Market Analysis, Insights and Forecast – By Segment 2
- 9.3.1. Sub-Segment 1
- 9.3.2. Sub-Segment 2
- 9.3.3. Sub-Segment 3
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast – By Segment 3
- 9.4.1. Sub-Segment 1
- 9.4.2. Sub-Segment 2
- 9.4.3. Sub-Segment 3
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. China
- 9.5.2. India
- 9.5.3. Japan
- 9.5.4. Australia
- 9.5.5. South East Asia
- 9.5.6. Rest of Asia Pacific
10. Middle East & Africa Immunodiagnostics Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Segment 1
- 10.2.1. Sub-Segment 1
- 10.2.2. Sub-Segment 2
- 10.3. Market Analysis, Insights and Forecast – By Segment 2
- 10.3.1. Sub-Segment 1
- 10.3.2. Sub-Segment 2
- 10.3.3. Sub-Segment 3
- 10.3.4. Others
- 10.4. Market Analysis, Insights and Forecast – By Segment 3
- 10.4.1. Sub-Segment 1
- 10.4.2. Sub-Segment 2
- 10.4.3. Sub-Segment 3
- 10.4.4. Others
- 10.5. Market Analysis, Insights and Forecast – By Country
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Company Market Share Analysis, 2018
- 11.2. Key Industry Developments
- 11.3. Company Profile
- 11.3.1. Company 1
- 11.3.1.1. Business Overview
- 11.3.1.2. Segment 1 & Service Offering
- 11.3.1.3. Overall Revenue
- 11.3.1.4. Geographic Presence
- 11.3.1.5. Recent Development
*Similar details will be provided for the following companies- 11.3.2. Company 2
- 11.3.3. Company 3
- 11.3.4. Company 4
- 11.3.5. Company 5
- 11.3.6. Company 6
- 11.3.7. Company 7
- 11.3.8. Company 8
- 11.3.9. Company 9
- 11.3.10. Company 10
- 11.3.11. Company 11
- 11.3.12. Company 12
List of Figures
Figure 1: Global Immunodiagnostics Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
Figure 2: Global Immunodiagnostics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 3: Global Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 4: Global Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 5: Global Immunodiagnostics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 6: Global Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 7: Global Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 8: Global Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 9: Global Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 10: Global Immunodiagnostics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 11: Global Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 12: Global Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 13: Global Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 14: Global Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 15: Global Immunodiagnostics Market Value (USD Billion), by Region, 2019 & 2027
Figure 16: North America Immunodiagnostics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 17: North America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 18: North America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 19: North America Immunodiagnostics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 20: North America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 21: North America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 22: North America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 23: North America Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 24: North America Immunodiagnostics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 25: North America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 26: North America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 27: North America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 28: North America Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 29: North America Immunodiagnostics Market Forecast (USD Billion), by U.S., 2016-2027
Figure 30: North America Immunodiagnostics Market Forecast (USD Billion), by Canada, 2016-2027
Figure 31: Latin America Immunodiagnostics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 32: Latin America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 33: Latin America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 34: Latin America Immunodiagnostics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 35: Latin America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 36: Latin America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 37: Latin America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 38: Latin America Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 39: Latin America Immunodiagnostics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 40: Latin America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 41: Latin America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 42: Latin America Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 43: Latin America Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 44: Latin America Immunodiagnostics Market Forecast (USD Billion), by Brazil, 2016-2027
Figure 45: Latin America Immunodiagnostics Market Forecast (USD Billion), by Mexico, 2016-2027
Figure 46: Latin America Immunodiagnostics Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
Figure 47: Europe Immunodiagnostics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 48: Europe Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 49: Europe Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 50: Europe Immunodiagnostics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 51: Europe Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 52: Europe Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 53: Europe Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 54: Europe Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 55: Europe Immunodiagnostics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 56: Europe Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 57: Europe Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 58: Europe Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 59: Europe Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 60: Europe Immunodiagnostics Market Forecast (USD Billion), by U.K., 2016-2027
Figure 61: Europe Immunodiagnostics Market Forecast (USD Billion), by Germany, 2016-2027
Figure 62: Europe Immunodiagnostics Market Forecast (USD Billion), by France, 2016-2027
Figure 63: Europe Immunodiagnostics Market Forecast (USD Billion), by Italy, 2016-2027
Figure 64: Europe Immunodiagnostics Market Forecast (USD Billion), by Spain, 2016-2027
Figure 65: Europe Immunodiagnostics Market Forecast (USD Billion), by Russia, 2016-2027
Figure 66: Europe Immunodiagnostics Market Forecast (USD Billion), by Rest of Europe, 2016-2027
Figure 67: Asia Pacific Immunodiagnostics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 68: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 69: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 70: Asia Pacific Immunodiagnostics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 71: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 72: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 73: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 74: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 75: Asia Pacific Immunodiagnostics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 76: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 77: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 78: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 79: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 80: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by China, 2016-2027
Figure 81: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by India, 2016-2027
Figure 82: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Japan, 2016-2027
Figure 83: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Australia, 2016-2027
Figure 84: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Southeast Asia, 2016-2027
Figure 85: Asia Pacific Immunodiagnostics Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
Figure 86: Middle East & Africa Immunodiagnostics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 87: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 88: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 89: Middle East & Africa Immunodiagnostics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 90: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 91: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 92: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 93: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 94: Middle East & Africa Immunodiagnostics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 95: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 96: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 97: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 98: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Others, 2016-2027
Figure 99: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by GCC, 2016-2027
Figure 100: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by South Africa, 2016-2027
Figure 101: Middle East & Africa Immunodiagnostics Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027
List of Tables
Table 1: Global Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 2: Global Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 3: Global Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 4: Global Immunodiagnostics Market Revenue (USD Billion) Forecast, by Region, 2016-2027
Table 5: North America Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 6: North America Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 7: North America Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 8: North America Immunodiagnostics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 9: Europe Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 10: Europe Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 11: Europe Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 12: Europe Immunodiagnostics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 13: Latin America Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 14: Latin America Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 15: Latin America Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 16: Latin America Immunodiagnostics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 17: Asia Pacific Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 18: Asia Pacific Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 19: Asia Pacific Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 20: Asia Pacific Immunodiagnostics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 21: Middle East & Africa Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 22: Middle East & Africa Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 23: Middle East & Africa Immunodiagnostics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 24: Middle East & Africa Immunodiagnostics Market Revenue (USD Billion) Forecast, by Country, 2016-2027